Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Internal Medicine
•
Hematology
•
Sickle Cell
•
Benign Hematology
Would you start a patient with sickle cell disease and COVID-19 on prophylactic anticoagulation?
Related Questions
Is there any indication for hydroxyurea in patients with sickle cell trait?
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
Would you consider continuing or re-trialing hydroxyurea for sickle cell patients after development of a leg ulcer?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
What would you recommend for long term management of extensive dural venous sinus thrombosis (CVST) in young females when the only provoking risk factor is combined OCP?
What is your target Hgb/Hct for women who are pregnant and have sickle cell disease in whom you are doing scheduled transfusions?
How do you manage arthritis resulting from deferiprone in transfusion dependent thalassemia?
For von Willebrand type 2B, do you expect a decline in platelet count over time as vWF increases with age?
How would you treat suspected secondary HLH in patients whom etoposide is contraindicated?
